Swedish radiation therapy firm RaySearch has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its RayStation treatment planning system.
RayStation integrates all of RaySearch's treatment planning technology into one system, according to the Stockholm-based vendor. It includes the company's algorithms for optimizing intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT), as well as dose engines for both photon and proton therapy.
The system also will have support for 4D adaptive radiation therapy, RaySearch said.
Related Reading
RaySearch, Varian launch software, July 2, 2009
RaySearch, Philips launch SmartArc, April 22, 2009
RaySearch signs MGH research deal, August 13, 2008
RaySearch wins Swedish proton therapy contract, August 6, 2008
Copyright © 2010 AuntMinnie.com
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
